Novartis Restarts Production at Its Millburn, N.J. Facility

By PacConAdmin | June 30, 2022

Novartis said it has resumed operations at its Millburn, N.J., and Ivrea, Italy, plants after recently halting production over quality lapses related to the manufacture of radioligand therapy medicines.
Source: Drug Industry Daily

Posted in Drug Industry Daily